hydralazine has been researched along with Cardiac Death in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KLAYMAN, MI | 1 |
SILBERG, NR | 1 |
KARLEN, WS | 1 |
COMENS, P | 1 |
SCHROEDER, HA | 1 |
2 other studies available for hydralazine and Cardiac Death
Article | Year |
---|---|
Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
Topics: Cardiovascular Agents; Death; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; S | 1953 |
The L. E. cell as a manifestation of delayed hydralazine intoxication.
Topics: Child; Death; Death, Sudden; Humans; Hydralazine; Infant; Lupus Erythematosus, Systemic; Poisoning; | 1956 |